CoagulationDisorders near Nashville, TN

Care Philosophy: I have the privilege of caring for patients with life-threatening diseases who are often overwhelmed and dealing with the uncertainty of their prognosis, treatment options, and outcomes. In this context, I see my role as being their advocate, making sure I take the time to help them understand their options and provide them with the same care I would expect for myself or a close family member. I strive to build a relationship with my patients based on trust, honesty and compassion.For me, the essence of being a physician is the ability to make a difference and having the honor of working with patients who allow me to be a part of their cancer journey. I also get to lead an incredible team that is passionate about caring for transplant and cell therapy patients.I have had the fortune of learning from the diversity of our patients: where they come from, the uniqueness of their life circumstances and their ability to overcome challenges. I have learned to approach each patient with humility and compassion and deeply appreciate the challenges they and their loved ones go through as they navigate cancer treatment and recovery.

Biography: This physician is accepting telehealth visits. Minoo Battiwalla, M.D., M.S. joined Sarah Cannon in 2018 as the director of outcomes research. In his role, he designs and leads retrospective outcomes research across the Sarah Cannon Blood Cancer Network with a special emphasis on blood and marrow stem cell transplantation and cellular therapy.Dr. Battiwalla received his medical degree from Medical College in Calcutta, India in 1994. After completing an internal medicine residency at Stony Brook University Hospital, NY, he finished a fellowship in hematology/oncology/BMT at National Institutes of Health in Bethesda, MD. He also earned a Master of Health Science degree in clinical research in 2003 from Duke University School of Medicine.Prior to joining Sarah Cannon, Dr. Battiwalla served as the medical director of the Blood and Marrow Stem Cell Transplant Program at the National Heart, Lung and Blood Institute, Bethesda, MD from 2010-2018 and chaired the NIH BMT Consortium. Previous to this, he was an assistant professor and associate scientific director at the Roswell Park Cancer Institute, Buffalo, NY from 2003-2009.Dr. Battiwalla has spearheaded efforts in the field of stem cell transplant survivorship and has co-chaired the NIH Late Effects after BMT consensus initiative as well as the Center for International Blood and Marrow Transplantation Late Effects Working Committee.Dr. Battiwalla is actively certified by the American Board of Internal Medicine with further certification in Hematology.

Biography: Stephen Strickland, MD is a board-certified, fellowship-trained medical oncologist and hematologist at Tristar Bone Marrow Transplant located in Nashville, TN.Dr. Strickland is the Director of Leukemia Research for the Sarah Cannon Transplant & Cellular Therapy Network. In his role, Dr. Strickland provides scientific leadership and oversees Sarah Cannon's robust portfolio of clinical trials in leukemia, myelodysplastic syndromes, and related diseases.Dr. Strickland is affiliated with Tristar Centennial Medical Center and Sarah Cannon Cancer Institute. Additionally, Dr. Strickland is an internationally respected leukemia researcher with more than 100 peer-reviewed scientific publications and abstracts. He received his Doctor of Medicine from Louisiana State University School of Medicine in New Orleans and completed his internship/residency (Internal Medicine), clinical fellowship (Hematology/Oncology), and a Master of Science in Clinical Investigation at Vanderbilt University Medical Center.